|
|
|
Insider
Information: |
Parsey Merdad |
Relationship: |
Director |
City: |
Foster City |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
114,983 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$8,615,879 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
114,983 |
|
|
Total
Value |
$8,615,879 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
|
|
Stock
price went down : |
|
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Gilead Sciences Inc |
GILD |
Chief Medical Officer |
2024-09-12 |
102,189 |
2020-08-15 |
0 |
Premium* |
|
Sagimet Biosciences Inc. |
SGMT |
Director |
2023-07-18 |
12,794 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
57 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
SGMT |
Sagimet Biosciences Inc. |
Director |
|
2023-07-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
8,677 |
|
- |
|
GILD |
Gilead Sciences Inc |
Chief Medical Officer |
|
2021-08-15 |
4 |
A |
$55.08 |
$55 |
D/D |
1 |
14,080 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chief Medical Officer |
|
2020-08-15 |
4 |
A |
$57.43 |
$10,452 |
D/D |
182 |
182 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chief Medical Officer |
|
2020-08-17 |
4 |
AS |
$68.32 |
$12,434 |
D/D |
(182) |
0 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chief Medical Officer |
|
2022-02-15 |
4 |
A |
$52.13 |
$18,141 |
D/D |
348 |
41,613 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chief Medical Officer |
|
2021-02-15 |
4 |
A |
$56.86 |
$20,696 |
D/D |
364 |
12,263 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chief Medical Officer |
|
2023-02-15 |
4 |
A |
$56.38 |
$21,199 |
D/D |
376 |
83,114 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chief Medical Officer |
|
2022-09-10 |
4 |
D |
$65.28 |
$31,400 |
D/D |
(481) |
42,725 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chief Medical Officer |
|
2022-06-10 |
4 |
D |
$60.74 |
$29,459 |
D/D |
(485) |
42,167 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chief Medical Officer |
|
2022-12-10 |
4 |
D |
$87.97 |
$42,753 |
D/D |
(486) |
46,109 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chief Medical Officer |
|
2022-12-30 |
4 |
AS |
$85.33 |
$47,187 |
D/D |
(553) |
45,556 |
0 |
% |
|
GILD |
Gilead Sciences Inc |
Chief Medical Officer |
|
2022-06-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,039 |
42,652 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chief Medical Officer |
|
2022-09-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,039 |
43,206 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chief Medical Officer |
|
2022-12-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,039 |
46,595 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chief Medical Officer |
|
2023-12-10 |
4 |
D |
$79.02 |
$100,276 |
D/D |
(1,269) |
71,640 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chief Medical Officer |
|
2023-09-10 |
4 |
D |
$76.00 |
$97,128 |
D/D |
(1,278) |
71,631 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chief Medical Officer |
|
2023-06-10 |
4 |
D |
$78.12 |
$101,087 |
D/D |
(1,294) |
30,887 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chief Medical Officer |
|
2023-06-13 |
4 |
AS |
$76.90 |
$114,197 |
D/D |
(1,485) |
29,402 |
0 |
% |
|
GILD |
Gilead Sciences Inc |
Chief Medical Officer |
|
2023-09-12 |
4 |
AS |
$76.99 |
$115,562 |
D/D |
(1,501) |
70,130 |
0 |
% |
|
GILD |
Gilead Sciences Inc |
Chief Medical Officer |
|
2021-03-10 |
4 |
D |
$63.91 |
$104,748 |
D/D |
(1,639) |
14,079 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chief Medical Officer |
|
2024-06-10 |
4 |
D |
$65.25 |
$113,796 |
D/D |
(1,744) |
98,380 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chief Medical Officer |
|
2024-09-10 |
4 |
D |
$81.44 |
$143,823 |
D/D |
(1,766) |
98,435 |
0 |
- |
|
GILD |
Gilead Sciences Inc |
Chief Medical Officer |
|
2024-02-28 |
4 |
AS |
$73.18 |
$146,360 |
D/D |
(2,000) |
100,936 |
0 |
% |
|
GILD |
Gilead Sciences Inc |
Chief Medical Officer |
|
2024-04-01 |
4 |
AS |
$72.96 |
$145,920 |
D/D |
(2,000) |
96,304 |
0 |
% |
|
GILD |
Gilead Sciences Inc |
Chief Medical Officer |
|
2024-07-01 |
4 |
AS |
$68.63 |
$137,260 |
D/D |
(2,000) |
96,380 |
0 |
% |
|
57 Records found
|
|
Page 1 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|